Related Experiment Video
Updated: May 20, 2026

10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Tools to optimize the functionality of a leukemia clinical trial team
Beverly Bethelmie-Bryan1, Katharine Lord, Stacie Holloway
1Clinical Trials Office of Winship Cancer Institute of Emory University, Atlanta, GA, USA.
Leukemia & Lymphoma
|July 6, 2012
Summary
Integrating technology and a multidisciplinary team approach streamlines clinical trials. This strategy enhances efficiency, regulatory compliance, and facilitates trial integration into routine healthcare practices.
Area of Science:
- Clinical research operations
- Healthcare management
- Regulatory science
Background:
- Stringent regulatory requirements increase clinical trial workload.
- Multidisciplinary teams can improve efficiency and care quality.
- Integrating clinical trials into practice presents challenges.
Purpose of the Study:
- To describe tools and strategies for managing regulatory requirements in clinical trials.
- To demonstrate how technology and team coordination can optimize clinical trial conduct.
- To assess the feasibility of integrating clinical trials into routine clinical practice.
Main Methods:
- Implemented a multidisciplinary research team structure (hematologist, physician assistant, nurse coordinator, clinical research coordinators, investigational drug pharmacist, regulatory associate, data manager).
- Utilized technology tools and operational reorganization to manage workload and documentation.
- Focused on optimizing knowledge sharing, communication, and regulatory compliance.
Main Results:
- The combined approach of technology and coordinated team care facilitated high-volume patient enrollment.
- Consistent regulatory compliance was maintained despite increased workload.
- Optimized knowledge management, documentation, and communication processes were achieved.
Conclusions:
- Technology and a coordinated team care model are effective in managing complex regulatory demands in clinical trials.
- This integrated approach can successfully facilitate the incorporation of clinical trials into healthcare settings.
- The described model enhances efficiency and quality of care in clinical research.
Related Concept Videos
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
